Cell MedX Corp. logo

Cell MedX Corp. (CMXC)

Market Open
16 May, 20:00
OTCQB OTCQB
$
0. 39
-0
-0.67%
$
126.33M Market Cap
- P/E Ratio
0% Div Yield
820 Volume
0 Eps
$ 0.39
Previous Close
Day Range
0.25 0.39
Year Range
0.01 0.58

Summary

CMXC trading today lower at $0.39, a decrease of 0.67% from yesterday's close, completing a monthly increase of 48.39% or $0.13. Over the past 12 months, CMXC stock lost -22.52%.
CMXC is not paying dividends to its shareholders.
The last earnings report, released on Apr 14, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by 0%, based on the last three reports.
Cell MedX Corp. has completed 1 stock splits, with the recent split occurring on Nov 05, 2024.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTCQB (USD).
Want to track CMXC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

CMXC Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
StimCell Energetics Inc. (Formerly "Cell MedX Corp.") Announces Major Corporate Updates and Rebranding

StimCell Energetics Inc. (Formerly "Cell MedX Corp.") Announces Major Corporate Updates and Rebranding

VANCOUVER, BC / ACCESSWIRE / November 4, 2024 / StimCell Energetics Inc. (formerly "Cell MedX Corp.") (OTC PINK:CMXC) ("StimCell", or the "Company") a biotech company targeting cellular energy to promote anti-aging, longevity and general wellness, is pleased to announce a series of significant corporate changes designed to redefine the Company's strategic vision. StimCell Energetics Inc. Effective immediately, the Company has completed a corporate name change from "Cell MedX Corp." to "StimCell Energetics Inc." and completed a reverse split of its common stock on a 1 new share for 15 old shares basis (the "Reverse Split").

Accesswire | 7 months ago

Cell MedX Corp. Dividends

CMXC is not paying dividends to its shareholders.

Cell MedX Corp. Earnings

14 Apr 2025 Date
-
Cons. EPS
-
EPS
14 Jan 2025 Date
-
Cons. EPS
-
EPS
15 Oct 2024 Date
-
Cons. EPS
-
EPS
14 Oct 2024 Date
-
Cons. EPS
-
EPS
30 Aug 2024 Date
-
Cons. EPS
-
EPS
CMXC is not paying dividends to its shareholders.
14 Apr 2025 Date
-
Cons. EPS
-
EPS
14 Jan 2025 Date
-
Cons. EPS
-
EPS
15 Oct 2024 Date
-
Cons. EPS
-
EPS
14 Oct 2024 Date
-
Cons. EPS
-
EPS
30 Aug 2024 Date
-
Cons. EPS
-
EPS

Cell MedX Corp. (CMXC) FAQ

What is the stock price today?

The current price is $0.39.

On which exchange is it traded?

Cell MedX Corp. is listed on OTCQB.

What is its stock symbol?

The ticker symbol is CMXC.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 126.33M.

Has Cell MedX Corp. ever had a stock split?

Cell MedX Corp. had 1 splits and the recent split was on Nov 05, 2024.

Cell MedX Corp. Profile

Medical Devices Industry
Healthcare Sector
Mr. David M. Jeffs CEO
OTCQB Exchange
15115X107 Cusip
United States Country
- Employees
- Last Dividend
5 Nov 2024 Last Split
- IPO Date

Overview

Cell MedX Corp. is a pioneering biotech company engaged in the discovery, development, and commercialization of therapeutic and non-therapeutic products aimed primarily at diseases such as diabetes, Parkinson's disease, high blood pressure, neuropathy, and issues with kidney functions. Initially known as Sports Asylum, Inc., the company underwent a rebranding to Cell MedX Corp. in September 2014. Established in 2010 and based in Carson City, Nevada, Cell MedX Corp. focuses on bringing innovative solutions into the medical field, significantly improving the quality of life for patients suffering from chronic conditions through advanced technology.

Products and Services

  • eBalance Pro System
  • Designed for professional use by healthcare practitioners within clinical settings, the eBalance Pro System is an innovative device aimed at enhancing patient wellness and pain management. It operates through the eBalance Console, which serves as the central control unit, executing three pre-programmed microcurrent algorithms: wellness, pain management, and dual, tailored to address the therapeutic needs of patients.

  • eBalance Home System
  • This system is tailored for home use, promoting general wellness and aiding in pain management treatment. Similar to its professional counterpart, the Home System is driven by the eBalance Console, which manages the application of microcurrents in a user-friendly manner, allowing patients to enjoy the benefits of the technology in the comfort of their own homes. It is especially designed for the temporary relief of discomfort in various parts of the body, including the shoulders, waist, back, neck, arms, and legs, making it a versatile tool for managing a range of conditions.

Contact Information

Address: 123 West Nye Lane
Phone: 844 238 2692